Cargando…

Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII

BACKGROUND: Avascular necrosis is a common organ damage in SLE patients, which can influence patients’ life quality. Conflicting results exist in risk factors of AVN in SLE patients. The aim of this study was to illustrate risk factors predicting the occurrence of avascular necrosis (AVN), also know...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Cheng, Huang, Can, Chen, Zhen, Zhan, Feng, Duan, Xinwang, Wang, Yongfu, Zhao, Cheng, Wu, Zhenbiao, Xu, Jian, Li, Hongbin, Yang, Min, Wu, Rui, Zhao, Jiuliang, Zhang, Shangzhu, Wang, Qian, Leng, Xiaomei, Tian, Xinping, Li, Mengtao, Zeng, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176939/
https://www.ncbi.nlm.nih.gov/pubmed/37173771
http://dx.doi.org/10.1186/s13075-023-03061-3
_version_ 1785040524377325568
author Cheng, Cheng
Huang, Can
Chen, Zhen
Zhan, Feng
Duan, Xinwang
Wang, Yongfu
Zhao, Cheng
Wu, Zhenbiao
Xu, Jian
Li, Hongbin
Yang, Min
Wu, Rui
Zhao, Jiuliang
Zhang, Shangzhu
Wang, Qian
Leng, Xiaomei
Tian, Xinping
Li, Mengtao
Zeng, Xiaofeng
author_facet Cheng, Cheng
Huang, Can
Chen, Zhen
Zhan, Feng
Duan, Xinwang
Wang, Yongfu
Zhao, Cheng
Wu, Zhenbiao
Xu, Jian
Li, Hongbin
Yang, Min
Wu, Rui
Zhao, Jiuliang
Zhang, Shangzhu
Wang, Qian
Leng, Xiaomei
Tian, Xinping
Li, Mengtao
Zeng, Xiaofeng
author_sort Cheng, Cheng
collection PubMed
description BACKGROUND: Avascular necrosis is a common organ damage in SLE patients, which can influence patients’ life quality. Conflicting results exist in risk factors of AVN in SLE patients. The aim of this study was to illustrate risk factors predicting the occurrence of avascular necrosis (AVN), also known as osteonecrosis, in systemic lupus erythematosus (SLE) patients in Chinese SLE Treatment and Research Group (CSTAR), a multi-center cohort of Chinese SLE patients. METHODS: SLE patients in CSTAR without existing AVN at registration were included. At least two follow-ups and an observation period of no less than 2 years for AVN event were required. Univariate and multivariate Cox regression analyses were used to evaluate risk factors for AVN in SLE patients. Coefficient B was transformed to risk score for the development of a risk stratification model. RESULTS: One hundred six (2.59%) of 4091 SLE patients were diagnosed AVN during follow-ups of no less than 2 years. Multi-variate Cox regression analysis suggested that SLE onset age ≤ 30 (HR 1.616, p 0.023), arthritis (HR 1.642, p 0.018), existing organ damage (SDI ≥ 1) at registration (HR 2.610, p < 0.001), positive anti-RNP (HR 1.709, p 0.006), and high glucocorticoid maximum daily dose at registration (HR 1.747, p 0.02) were independent risk factors. A risk stratification system was developed according to the risk factors, and patients were divided into high risk (3–6) and low risk (0–2). The AUC of 0.692 indicated moderate discrimination. The calibration curve in internal validation was drawn. CONCLUSION: Patients with SLE onset age ≤ 30, arthritis, existing organ damage (SDI ≥ 1) at registration, positive anti-RNP, and high glucocorticoid maximum daily dose at registration are at high risk for AVN and require attention.
format Online
Article
Text
id pubmed-10176939
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101769392023-05-13 Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII Cheng, Cheng Huang, Can Chen, Zhen Zhan, Feng Duan, Xinwang Wang, Yongfu Zhao, Cheng Wu, Zhenbiao Xu, Jian Li, Hongbin Yang, Min Wu, Rui Zhao, Jiuliang Zhang, Shangzhu Wang, Qian Leng, Xiaomei Tian, Xinping Li, Mengtao Zeng, Xiaofeng Arthritis Res Ther Research BACKGROUND: Avascular necrosis is a common organ damage in SLE patients, which can influence patients’ life quality. Conflicting results exist in risk factors of AVN in SLE patients. The aim of this study was to illustrate risk factors predicting the occurrence of avascular necrosis (AVN), also known as osteonecrosis, in systemic lupus erythematosus (SLE) patients in Chinese SLE Treatment and Research Group (CSTAR), a multi-center cohort of Chinese SLE patients. METHODS: SLE patients in CSTAR without existing AVN at registration were included. At least two follow-ups and an observation period of no less than 2 years for AVN event were required. Univariate and multivariate Cox regression analyses were used to evaluate risk factors for AVN in SLE patients. Coefficient B was transformed to risk score for the development of a risk stratification model. RESULTS: One hundred six (2.59%) of 4091 SLE patients were diagnosed AVN during follow-ups of no less than 2 years. Multi-variate Cox regression analysis suggested that SLE onset age ≤ 30 (HR 1.616, p 0.023), arthritis (HR 1.642, p 0.018), existing organ damage (SDI ≥ 1) at registration (HR 2.610, p < 0.001), positive anti-RNP (HR 1.709, p 0.006), and high glucocorticoid maximum daily dose at registration (HR 1.747, p 0.02) were independent risk factors. A risk stratification system was developed according to the risk factors, and patients were divided into high risk (3–6) and low risk (0–2). The AUC of 0.692 indicated moderate discrimination. The calibration curve in internal validation was drawn. CONCLUSION: Patients with SLE onset age ≤ 30, arthritis, existing organ damage (SDI ≥ 1) at registration, positive anti-RNP, and high glucocorticoid maximum daily dose at registration are at high risk for AVN and require attention. BioMed Central 2023-05-12 2023 /pmc/articles/PMC10176939/ /pubmed/37173771 http://dx.doi.org/10.1186/s13075-023-03061-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cheng, Cheng
Huang, Can
Chen, Zhen
Zhan, Feng
Duan, Xinwang
Wang, Yongfu
Zhao, Cheng
Wu, Zhenbiao
Xu, Jian
Li, Hongbin
Yang, Min
Wu, Rui
Zhao, Jiuliang
Zhang, Shangzhu
Wang, Qian
Leng, Xiaomei
Tian, Xinping
Li, Mengtao
Zeng, Xiaofeng
Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
title Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
title_full Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
title_fullStr Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
title_full_unstemmed Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
title_short Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
title_sort risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of chinese sle treatment and research group (cstar) registry xxii
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176939/
https://www.ncbi.nlm.nih.gov/pubmed/37173771
http://dx.doi.org/10.1186/s13075-023-03061-3
work_keys_str_mv AT chengcheng riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT huangcan riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT chenzhen riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT zhanfeng riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT duanxinwang riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT wangyongfu riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT zhaocheng riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT wuzhenbiao riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT xujian riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT lihongbin riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT yangmin riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT wurui riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT zhaojiuliang riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT zhangshangzhu riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT wangqian riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT lengxiaomei riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT tianxinping riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT limengtao riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii
AT zengxiaofeng riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii